Structure and function of the HCV RNA replicase
Structure and function of the HCV RNA replicase
批准号:
8026869
负责人:
Charles M Rice
金额:
$37.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2014-02-28
关键词:
AddressAnimal ModelAntiviral AgentsApplications GrantsBindingBiochemicalBiochemical GeneticsBiochemistryBiological AssayCell Culture TechniquesCell-Free SystemCellsChimera organismChronicChronic Hepatitis CCirrhosisClinicalComplementComplexCoupledCultured CellsDataDevelopmentDrug Delivery SystemsElementsEnzymesGeneticGenomeGenomicsGoalsHealthHepatitis C virusHoloenzymesHumanIn VitroIndividualInfectionIntegration Host FactorsLengthLife Cycle StagesLinkLiver FailureLiver diseasesMalignant NeoplasmsMediatingMolecularMolecular BiologyMolecular CloningNonstructural ProteinPathogenesisPeptide HydrolasesPolymerasePolyproteinsPrimary carcinoma of the liver cellsProcessProtease DomainProteinsRNARNA BindingRNA chemical synthesisRNA replicationRNA-Directed RNA PolymeraseReagentRepliconResearchResistanceResolutionRiskRoleSchemeStructureSurfaceSystemTherapeutic InterventionTranslationsViralViral ProteinsViral hepatitisVirusVirus DiseasesVirus ReplicationX-Ray Crystallographyeffective therapygenetic analysisgenome-wide analysishelicaseinhibitor/antagonistinsightliver transplantationnovelpathogenprotein complexprotein protein interactionreplicasetoolviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) is the etiologic agent of parenterally transmitted non-A, non-B viral hepatitis. Chronic infection puts individuals at risk for the development of cirrhosis, hepatocellular carcinoma, and liver failure, making chronic hepatitis C the leading indication for liver transplantation. While HCV-specific protease and polymerase inhibitors are showing promise in early clinical development, rapid emergence of resistance indicates that additional viral targets and combinations of antivirals will be needed for effective control. We propose to investigate the structure and function of the replicase complex, the central holoenzyme of HCV replication. Increased understanding of how the components of this complex come together, as well as clarifying the functions and mechanisms of each constituent, will facilitate the development of novel antiviral drugs. We will use genetic analyses complemented with biochemical studies to investigate protein-protein interactions within the replication complex. These studies will provide a context in which to build a structural understanding of the replicase. We then aim to elucidate the roles of two important but enigmatic viral proteins, the NS3 helicase and NS5A. These proteins, both potentially extremely valuable drug targets, have as-yet-unknown roles in RNA replication. We will investigate the mechanism of NS3 helicase activity and the roles of this enzyme in the viral life cycle using X-ray crystallography and complementary genetic approaches. We will pursue an atomic-resolution structure of full-length NS5A, as well as investigate its structure in complex with an RNA substrate. We will also attempt to develop cell-free replication assays for HCV; the current lack of such systems is a major roadblock to studies of this virus. Availability of a cell-free assay would allow us to relate structural, biochemical, and genetic data to specific steps of RNA synthesis. Through these studies, we hope to begin to understand mechanisms of HCV RNA replication and to uncover novel avenues for therapeutic intervention. PUBLIC HEALTH RELEVANCE: Hepatitis C virus is a leading cause of liver disease including cancer. This proposal aims to study the structure and function of the protein complex that replicates the virus genome. The resulting findings should aid development of more effective treatments aimed at eradicating this deadly viral disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Employing viruses to unravel the functional significance of the m5C epitranscriptome
-
批准号:10638533
-
项目类别:
-
资助金额:$66.0万
-
财政年份:2023
-
负责人:Charles M Rice
-
依托单位:
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
-
批准号:10667182
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2023
-
负责人:Charles M Rice
-
依托单位:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
-
批准号:10446423
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
-
批准号:10553697
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
-
批准号:10570297
-
项目类别:
-
资助金额:$61.93万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Scientific Core: BSL3 Virology and Animal Models
-
批准号:10327991
-
项目类别:
-
资助金额:$145.45万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Scientific Core: BSL3 Virology and Animal Models
-
批准号:10841239
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
-
批准号:10446620
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
Virology Core
-
批准号:10513915
-
项目类别:
-
资助金额:$528.97万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
-
批准号:10587597
-
项目类别:
-
资助金额:$46.09万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
-
批准号:10707260
-
项目类别:
-
资助金额:$61.01万
-
财政年份:2022
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10576892
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10360541
-
项目类别:
-
资助金额:$49.43万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
-
批准号:10211567
-
项目类别:
-
资助金额:$50.99万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
Defining therapeutic drug targets for SARS-CoV-2-specific and pan-coronavirus inhibition
-
批准号:10238377
-
项目类别:
-
资助金额:$48.35万
-
财政年份:2021
-
负责人:Charles M Rice
-
依托单位:
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
-
批准号:10555333
-
项目类别:
-
资助金额:$61.11万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
Identification of host factors required by the tick-borne Powassan virus
-
批准号:10307148
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
Identification of host factors required by the tick-borne Powassan virus
-
批准号:10154884
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2020
-
负责人:Charles M Rice
-
依托单位:
In search of an HBV cure: novel model systems and targets
-
批准号:10400212
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
HEP DART 2019: Frontiers in Drug Development for Hepatology
-
批准号:9914390
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2019
-
负责人:Charles M Rice
-
依托单位:
海外基金